Challenges in diagnosis and management of cryptococcal immune reconstitution inflammatory syndrome (IRIS) in resource limited settings

African Health Sciences

Volumn 12, Issue 2, 2012, Pages 226-230

  Musubire, K B ^a   Meya, B D ^a,b   Mayanja Kizza, H ^a   Lukande, R ^a   Wiesner, L D ^b   Bohjanen, P ^b   Boulware, R D R ^b  

^a MAKERERE UNIVERSITY   (Uganda)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

AIDS; Antiretroviral therapy; Cryptococcal meningitis; HIV; Immune reconstitution inflammatory syndrome

Indexed keywords

ALBENDAZOLE; AMPHOTERICIN B; CORTICOSTEROID; COTRIMOXAZOLE; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; FLUCONAZOLE; PREDNISOLONE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADD ON THERAPY; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CASE REPORT; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID CULTURE; CRYPTOCOCCAL MENINGITIS; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DEATH; DRUG DOSE REDUCTION; DRUG MEGADOSE; FUNGUS CULTURE; HEALTH CARE PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYDROCEPHALUS; IMAGING; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; MEDICAL DECISION MAKING; RECURRENCE RISK; RELAPSE;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; AMPHOTERICIN B; ANTI-HIV AGENTS; ANTIFUNGAL AGENTS; CRYPTOCOCCUS NEOFORMANS; DISEASE MANAGEMENT; FATAL OUTCOME; FLUCONAZOLE; HEALTH RESOURCES; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; MALE; MENINGITIS, CRYPTOCOCCAL; RECURRENCE; UGANDA;

EID: 84864355118     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: 10.4314/ahs.v12i2.23     Document Type: Article

References (13)

1. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS. 2008;22(15):1897-908.
2. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009;23(4):525-530.
3. Boulware DR, Meya DB, Bergemann TL, Wiesner DL, Rhein J, Musubire A, et al. Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort study. PLoS Med. 2010;7(12):e1000384.
4. Haddow LJ, Colebunders R, Meintjes G, Lawn SD, Elliott JH, Manabe YC, et al. Cryptococcal immune reconstitution inflammatory syndrome in HIV-1-infected individuals: proposed clinical case definitions. Lancet Infect Dis. 2010;10(11):791-802.
5. Jarvis JN, Harrison TS. HIV-associated cryptococcal meningitis. AIDS. 2007;21(16):2119-29.
6. Meya DB, Manabe YC, Castelnuovo B, Cook BA, Elbireer AM, Kambugu A, et al. Costeffectiveness of serum cryptococcal antigen screening to prevent deaths among HIV-infected persons with a CD4+ cell count < or = 100 cells/microL who start HIV therapy in resource-limited settings. Clin Infect Dis. 2010;51(4):448-55.
7. Jarvis JN, Lawn SD, Vogt M, Bangani N, Wood R, Harrison TS. Screening for cryptococcal antigenemia in patients accessing an antiretroviral treatment program in South Africa. Clin Infect Dis. 2009;48(7):856-62.
8. Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, et al. Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:291-322.
9. Drouet A, Amah Y, Pavic M, Gerome P, Meyer X.P.D. Subacute meningoradiculomyeloencephalitis due to cryptococcosis infection. Rev Med Interne. 2005;26:403-8.
10. Gultasli NZ, Ercan K, Orhun S, Albayrak S. MRI findings of intramedullary spinal cryptococcoma. Diagnostic and interventional radiology. 2007;13(2):64-67.
11. Breton G, Seilhean D, Cherin P, Herson S, Benveniste O. Paradoxical intracranial cryptococcoma in a human immunodeficiency virus-infected man being treated with combination antiretroviral therapy. Am J Med. 2002;113(2):155-157.
12. Bicanic T, Harrison T, Niepieklo A, Dyakopu N, Meintjes G. Symptomatic relapse of HIVassociated cryptococcal meningitis after initial fluconazole monotherapy: the role of fluconazole resistance and immune reconstitution. Clin Infect Dis. 2006;43(8):1069-1073.
13. Jarvis JN, Meintjes G, Williams Z, Rebe K, Harrison TS. Symptomatic relapse of HIV